Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug-eluting stents may cause allergic reactions

21.12.2005


Researchers from Northwestern Memorial recommend physicians be vigilant in looking for symptoms



Drug-eluting stents have greatly reduced the risk of repeat blockage of heart arteries, but researchers from Northwestern Memorial Hospital have found that in some patients, the stents can cause allergic reactions that can have serious consequences. They stress that physicians and their patients should be aware of this potential and know the symptoms. The findings have been published online will be published in the January 3rd issue of the Journal of the American College of Cardiology.

"This paper provides evidence for the first time that instances of allergic reactions, presumably to the polymer in the stent, can occur. In some instances, these events have serious consequences- including stent closure and subsequent death," says one of the study’s authors, Charles Bennett, MD, an epidemiologist and oncologist at Northwestern Memorial Hospital and professor of medicine at Northwestern University’s Feinberg School of Medicine. Dr. Bennett developed and directs the Research on Adverse Drug/Device Events And Reports (RADAR) Project, which compiles information from reports submitted to the U.S. Food and Drug Administration’s (FDA) database as well as reports by drug companies and independent researchers throughout the world. RADAR has previously successfully identified a large number of serious drug reactions associated with 15 commonly used drugs.


For this study, RADAR investigators from 10 centers around the country reviewed 5,783 reports available from April 2003 through December 2004 for hypersensitivity-like reactions associated with drug-eluting stents. From these reports, researchers identified 17 cases of hypersensitivity reactions that were classified as probably or certainly caused the stent, four of which resulted in death. Symptoms included rash, difficulty breathing, hives, itching and fevers. They also concluded that the polymer coating on the stent itself is the most probable cause of hypersensitivity in the majority of cases rather than the medications the stent is coated with.

"It is important to keep the findings in perspective," says Charles J. Davidson, MD, an author on the paper and medical director of the Cardiac Catheterization Lab at the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital and professor of Medicine at Northwestern University’s Feinberg School of Medicine. "Drug-eluting stents are a life-saving advance used by hundreds of thousands of people that have greatly reduced the risk of restenosis. We are in no way recommending they be used less, but we do think that health professionals should be vigilant in watching for this problem."

Another concern, say the authors, is that in many instances, blame for the allergic symptoms is placed on other medications that treat their heart conditions, such as Plavix® and anti-platelet agents, and these are discontinued. Premature discontinuation of Plavix® can increase the risk of dangerous blood clots.

"Physicians should be cognizant that allergic reactions to the polymers in drug eluting stents can occur and all such events should be reported to the FDA. Six months after the approval of the first drug-eluting stent, the FDA issued a letter to physicians identifying 50 hypersensitivity cases associated with drug-eluting coronary artery stents, but retracted an assertion of causality a month later. That retraction may have been premature," says Dr. Bennett.

The paper also concludes that further research is warranted to better understand this risk and to develop a skin test to identify people who might be at high risk for hypersensitivity to drug eluting stents.

Amanda Widtfeldt | EurekAlert!
Further information:
http://www.nmh.org

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

Diving robots find Antarctic seas exhale surprising amounts of carbon dioxide in winter

16.08.2018 | Earth Sciences

Protein droplets keep neurons at the ready and immune system in balance

16.08.2018 | Life Sciences

3D inks that can be erased selectively

16.08.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>